middle.news
How Arovella’s $20.9M War Chest Fuels Next-Gen CAR-iNKT Trials
10:42am on Monday 28th of July, 2025 AEST
•
Biotechnology
Read Story
How Arovella’s $20.9M War Chest Fuels Next-Gen CAR-iNKT Trials
10:42am on Monday 28th of July, 2025 AEST
Key Points
Strong cash balance of $20.9 million at June 30, 2025
Progress on IND application and GMP manufacturing for lead product ALA-101
Exclusive option secured from Baylor College of Medicine for novel CARs targeting GD2 and GPC3
New Senior Director of Clinical Development appointed ahead of Phase 1 trial
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ALA
OPEN ARTICLE